These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 12358276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
    Suzuki F, Tsubota A, Akuta N, Someya T, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Miyakawa Y, Kumada H.
    J Gastroenterol; 2002; 37(11):922-7. PubMed ID: 12483247
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chronic hepatitis B: back to the future with HBsAg.
    Moucari R, Lada O, Marcellin P.
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
    [No Abstract] [Full Text] [Related]

  • 5. [Lamivudine treatment for hepatitis B].
    Lamivudine Clincal Practice Group.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
    [No Abstract] [Full Text] [Related]

  • 6. Remission of breakthrough hepatitis in chronic hepatitis B patients on lamivudine.
    Koike K.
    J Gastroenterol; 2002 Jul; 37(11):988-90. PubMed ID: 12483259
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F, Arikan C, Sertoz RY, Nart D, Aydogdu S, Yagci RV.
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Chronic hepatitis-b-virus infections: new options for antiviral therapy].
    de Man RA, Honkoop P, Janssen HL, Schalm SW.
    Ned Tijdschr Geneeskd; 1999 Sep 11; 143(37):1857-61. PubMed ID: 10526598
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined interferon and lamivudine therapy: is this the treatment of choice for patients with chronic hepatitis B virus infection?
    Terrault NA.
    Hepatology; 2000 Sep 11; 32(3):675-7. PubMed ID: 10991635
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.
    J Med Virol; 2007 Nov 11; 79(11):1664-70. PubMed ID: 17854034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.
    Viganò M, Colombo M, Aroldi A, Lunghi G, Manenti E, Ponticelli C, Lampertico P.
    Antivir Ther; 2005 Nov 11; 10(6):709-13. PubMed ID: 16218169
    [Abstract] [Full Text] [Related]

  • 20. [Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Marcellin P, Lada O.
    Gastroenterol Clin Biol; 2006 Oct 11; 30(10 Pt 2):3S5-8. PubMed ID: 17075487
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.